Department of Molecular Genetics and the Comprehensive Cancer Center, Ohio State University, Columbus; and
Departments of Microbiology and Biochemistry and the Centre for Molecular and Cellular Biology, University of Queensland, Brisbane, Australia
Correspondence: Michael C. Ostrowski, Department of Molecular Genetics, Ohio State University, 484 W. 12th Ave., Columbus, OH 43210. E-mail: ostrowski.4{at}osu.edu
The microphthalmia transcription factor (MITF) regulates gene expression during differentiation of several distinct cell types, including osteoclasts. A structure/function analysis was performed to determine whether transcription activation domains were important for MITF action in osteoclasts. In addition to a previously characterized acidic activation necessary for melanocyte differentiation, the analysis defined a second potential activation domain located between amino acids 140 and 185. This second domain is required for MITF transactivation of two probable targets, the E-cadherin promoter and the tartrate-resistant acid phosphatase promoter, in transient transfection assays. An intact MITF gene rescued differentiation when introduced into osteoclasts derived from mi/mi mice using a retrovirus vector. In parallel experiments, an MITF gene lacking the acidic-activation domain rescued differentiation twofold less efficiently than wild type, and a gene lacking the region between amino acid residues 140 and 185 rescued differentiation tenfold less efficiently than wild type. The results indicate that the N-terminal region of MITF is necessary for activation of gene expression in osteoclasts and provides one mechanism by which this factor regulates distinct target genes in different cell types.
Key Words: transcriptional regulation • myeloid differentiation • E-cadherin
This article has been cited by other articles:
 |
|
 |
|
  R. Hu, S. M. Sharma, A. Bronisz, R. Srinivasan, U. Sankar, and M. C. Ostrowski Eos, MITF, and PU.1 Recruit Corepressors to Osteoclast-Specific Genes in Committed Myeloid Progenitors Mol. Cell. Biol., June 1, 2007; 27(11): 4018 - 4027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Sharma, A. Bronisz, R. Hu, K. Patel, K. C. Mansky, S. Sif, and M. C. Ostrowski MITF and PU.1 Recruit p38 MAPK and NFATc1 to Target Genes during Osteoclast Differentiation J. Biol. Chem., May 25, 2007; 282(21): 15921 - 15929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Meadows, S. M. Sharma, G. J. Faulkner, M. C. Ostrowski, D. A. Hume, and A. I. Cassady The Expression of Clcn7 and Ostm1 in Osteoclasts Is Coregulated by Microphthalmia Transcription Factor J. Biol. Chem., January 19, 2007; 282(3): 1891 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Mbalaviele, G. Anderson, A. Jones, P. De Ciechi, S. Settle, S. Mnich, M. Thiede, Y. Abu-Amer, J. Portanova, and J. Monahan Inhibition of p38 Mitogen-Activated Protein Kinase Prevents Inflammatory Bone Destruction J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1044 - 1053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Roundy, G. Spangrude, J. J. Weis, and J. H. Weis Partial rescue of B cells in microphthalmic osteopetrotic marrow by loss of response to type I IFNs Int. Immunol., November 1, 2005; 17(11): 1495 - 1503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Huan, D. Sashital, T. Hailemariam, M. L. Kelly, and C. A. J. Roman Renal Carcinoma-associated Transcription Factors TFE3 and TFEB Are Leukemia Inhibitory Factor-responsive Transcription Activators of E-cadherin J. Biol. Chem., August 26, 2005; 280(34): 30225 - 30235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Mansky, U. Sankar, J. Han, and M. C. Ostrowski Microphthalmia Transcription Factor Is a Target of the p38 MAPK Pathway in Response to Receptor Activator of NF-kappa B Ligand Signaling J. Biol. Chem., March 22, 2002; 277(13): 11077 - 11083. [Abstract] [Full Text] [PDF]
|
|
